Life sciences briefing: Thursday, Feb. 21, 2008
TODAY’S HEADLINES:
Compact ultrasound maker Zonare Medical raises $30M (VentureWire)
TherOx raises $30M for hypersaturated-oxygen devices (peHUB)
Accumetrics, antiplatelet-drug diagnostic maker, raises $29M (release)
Population Genetics takes in £3.8M for massively parallel genome studies (GenomeWeb)
“Brain fitness” trainer Dakim raises $11M (release)
BioIQ, home-diagnostics maker, takes in $2.5M (release)
Hospital med-tracker Sabal Medical raises funds (release)
Seattle’s PharmaIN gets $400K NIH grant for nanoparticle staph drug (PDF release)
SensiGen, molecular-diagnostics developer, receives Michigan state loan (release)
Arcus Ventures aims for $50M fund, targets cancer (VentureWire)
Compact… Continue Reading
Life sciences briefing: Tuesday, Feb. 19, 2008
TODAY’S HEADLINES
Sonoma Ortho names Glen Coleman as CEO, preps launch of bone implant (VentureWire)
TechniScan draws $13M for ultrasound CT scanners (release)
OrbiMed plans $150M Asian life-science fund (VentureWire)
Accelerated Tech pulls in $47M, aims for $125M in second med-tech fund (VentureWire)
Amedisys buys out TLC Health Care for $395M (release)
Intertek acquires microbe measurer CML Biotech (release)
Medical-device maker Cianna Medical names Jill Anderson as CEO (release)
Sonoma Ortho names Glen Coleman as CEO, preps launch of bone implant – Santa Rosa,… Continue Reading
Medical imager Point Biomedical recaps with $25M
Point Biomedical, a San Carlos, Calif., developer of new biomedical-imaging products, raised $25 million in a recapitalization, peHub reports. Such recapitalizations often amount to a kind of “reset button” for existing investors and lenders, and usually suggest that a startup has run into some kind of significant — but not insurmountable — obstacle.
Investors in the recap round include new investor Vedanta Opportunities Fund and existing investors William Blair Capital Partners, De Novo Ventures, Institutional Venture… Continue Reading
Life sciences briefing: Wednesday, Nov. 28, 2007
Featured companies: American Aerogel, Clinicient, Frazier Healthcare Ventures, Genome Diagnostics, RadPharm, RainDance Technologies, Vivacta
UPDATED: Expanded items on Vitae, RadPharm, Vivacta and Genome Diagnostics. Intelligent Bio-Systems is now covered in a standalone item here.
Vitae Pharma takes in $15M for blood pressure, diabetes drugs — Vitae Pharmaceuticals, a Fort Washington, Pa., biotech focused on new drugs for hypertension and metabolic disorders, raised $15 million in a fourth funding round, VentureWire reports (subscription required). Boehringer Ingelheim, which struck a major… Continue Reading
Life sciences briefing: Friday, Nov. 16, 2007
Featured companies: ActiViews, ChemShop, Freedom-2
ActiViews raises $5M for medical-imaging systems — Israel’s ActiViews, a developer of technology for enhancing MRI and PET scans, raised $5 million in a first funding round. Investors included Ofer Hi Tech and Evergreen Venture Partners.
ActiView’s system provides real-time analysis of medical images used to guide invasive surgical procedures. Current practice often requires multiple scans, which are expensive and involve radiation exposure that can cause further harm. ActiView’s technology is designed to… Continue Reading
Life sciences briefing: Friday, Sept. 28, 2007
Featured companies: Imalux, Sagent Pharmaceuticals, Sequel Pharmaceuticals, Sinexus, TranS1, U.S. Spinal Technologies
Sagent Pharmaceuticals draws in $53M for injectable generics — Sagent Pharmaceuticals, proving that there’s still life in the apparently lucrative but boring specialty-pharmaceuticals business, raised $53 million in a first funding round. Vivo Ventures led the round for the Schaumburg, Ill., company.
Like other specialty pharmas, Sagent essentially picks up abandoned or cast-off drugs from other companies and tries to make them work in new ways…. Continue Reading